Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

Stopped early · Not applicable

Conditions studied: Heart Failure (for Example, Fluid Overload), Heart Failure, Fluid Overload

In brief

The REVERSE-HF study is a randomized controlled trial to evaluate clinical outcomes of adjustable ultrafiltration with the Aquadex System as compared to adjustable IV loop diuretics in patients with worsening heart failure (HF) and fluid overload.

Key facts

Study ID
NCT05318105
Run by
Nuwellis, Inc.
People needed
167
Starts
2022-06-28
Expected to finish
2026-04-07
Last updated by the study team
2026-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.